Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,271 public trials 1,197 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, not recruiting

A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors

NCT05888831

Conditions
Advanced Solid Tumors, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • Local Institution - 0021 Los Angeles, California, United States
  • Local Institution - 0007 New Haven, Connecticut, United States
  • Local Institution - 0010 Hackensack, New Jersey, United States
  • Local Institution - 0022 Lake Success, New York, United States
View all 20 locations
View Trial Details
Active, not recruiting

A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer

NCT03800134

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Duarte, California, United States
  • Research Site Orange, California, United States
  • Research Site Aurora, Colorado, United States
View all 231 locations
View Trial Details
Active, not recruiting

Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small Cell Lung Cancer

NCT02041845

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Rigshospitalet København Copenhagen, Denmark
  • Odense University Hospital Odense, Denmark
  • Ålesund sykehus Ålesund, Norway
  • Haukeland Universitetssykehus Bergen, Norway
View all 22 locations
View Trial Details
Active, not recruiting

A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer Patients

NCT03390686

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Alexandrov Cancer Center Minsk, Minsk City, Belarus
  • MHAT "Dr. Tota Venkova", AD Gabrovo, Bulgaria
  • CHC Osijek Osijek, Osijecko-baranjska, Croatia
  • LTD "High Technology Hospital Medcenter" Batumi, Georgia
View all 18 locations
View Trial Details
Active, not recruiting

Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC

NCT03970746

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Grand Hôpital de Charleroi Charleroi, Belgium
  • Jessa Ziekenhuis Hasselt, Belgium
  • AZ Groeninge Kortrijk, Belgium
  • University Hospitals KU Leuven Leuven, Belgium
View all 16 locations
View Trial Details
Active, not recruiting

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

NCT05704985

Conditions
Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +42 more
Locations
  • City of Hope Duarte, California, United States
  • Northwell Health Manhasset, New York, United States
  • OU Health Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Mary Crowley Cancer Research Dallas, Texas, United States
View Trial Details

Related conditions